Try our Advanced Search for more refined results
November 15, 2018
Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.
Case Number:
1:18-cv-01802
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 17, 2022
Roche Unit Nets $775M Deal In AstraZeneca IP Row
A month after AstraZeneca's Alexion Pharmaceuticals settled claims that its antibody product Ultomiris infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. Ltd., Chugai's attorneys said Thursday the settlement netted their client $775 million.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login